Streetbeat News

Products Services

AAPL

Air India, owned by Tata Group, is exploring potential collaborations with Apple Inc. The airline's CEO, Campbell Wilson, visited Apple's main office in Palo Alto, California. This collaboration may signify a broader strategy for both companies. Apple's recent endeavors in India, such as record-breaking sales at its new retail stores and plans to open three more flagship stores, highlight its growing interest in the Indian market. A Bank of America report suggests that by 2025, India might account for 18% of Apple's global iPhone production. Air India has been seeking to expand its fleet since going private, signing agreements to acquire 470 new planes from Boeing and Airbus last month.

Portfolio Pulse from Benzinga

July 21, 2023 | 2:22 pm

GOOG

GOOGL

Sergey Brin, co-founder of Google, has been actively involved in the company's operations, visiting the offices three to four days a week. He is working with researchers on the development of Google's next large AI system.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 2:14 pm

META

Meta Platforms Inc (NASDAQ:META) has announced its plan to provide free access to LLaMa 2, its advanced AI technology, as an open-source project. This move positions Meta as a significant competitor in the AI race against OpenAI. Despite a recent 4.27% downturn in Meta's shares, the company's stock has shown significant momentum this year, with a rise of over 146%. The $300 level is seen as a significant support level for the stock.

Portfolio Pulse from Zaheer Anwari

July 21, 2023 | 2:12 pm

IXHL

Incannex Healthcare Limited (NASDAQ:IXHL) has submitted an Investigational New Drug (IND) application to the US FDA for IHL-42X, a dronabinol-based drug for the treatment of obstructive sleep apnea. The IND includes comprehensive information on the safety, efficacy, development, manufacturing, and quality of IHL-42X. The clinical trial protocol for the IND opening clinical trial, a multi-site phase 2/3 clinical trial, is also detailed in the application.

Portfolio Pulse from Vuk Zdinjak

July 21, 2023 | 2:09 pm

GOOG

GOOGL

Google is reportedly developing an AI tool, Genesis, aimed at assisting journalists in their work. The tool was demonstrated to media executives from the New York Times, Washington Post, and News Corp. However, the media industry has ongoing issues with Google, including a lawsuit from newspaper giant Gannett, alleging that Google's adtech monopolies have damaged local news.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 2:06 pm

UAL

United Airlines Holdings (NASDAQ:UAL) plans to reduce flight frequencies at its Newark, N.J., hub to better manage weather disruptions and congestion. The company recently faced several days of disruption, with storms forcing the cancellation of roughly 7,900 flights in the last week of June. United compensated affected passengers with 30,000 frequent flyer miles. The company reported Q2 earnings of $5.03 per share, beating the analyst consensus estimate of $4.03, and quarterly sales of $14.18 billion, surpassing the analyst consensus of $13.91 billion.

Portfolio Pulse from Akanksha Bakshi

July 21, 2023 | 2:02 pm

AAPL

Apple Inc.'s MacBook Pro 16-inch with M2 Max chip is now available at a $1,600 discount on B&H Photo. The deal applies to the 32GB RAM and 1TB SSD configuration in both Silver and Space Gray colors. The M2 Max-powered MacBook Pro, launched in 2023, is Apple's most powerful laptop yet, featuring a 16.2-inch Liquid Retina XDR display, a 12-core CPU, a 30-core GPU, and up to 22 hours of battery life.

Portfolio Pulse from Rounak Jain

July 21, 2023 | 1:56 pm

CDTX

JNJ

Janssen Pharmaceuticals, a part of Johnson & Johnson, has announced its intention to discontinue the internal development of most of its infectious disease pipeline, including JNJ-0953 (CD388), a program for the prevention of influenza A and B, which is under an exclusive worldwide license and collaboration agreement with Cidara Therapeutics. However, Janssen has not informed Cidara of any intention to terminate the agreement. Cidara continues to collaborate with Janssen to complete the Phase 1 and Phase 2a clinical trials and will be reimbursed for all ongoing development activities by Janssen as per the collaboration agreement.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 1:52 pm

ALMPY

DSNKY

NVS

The FDA has approved Daiichi Sankyo's Vanflyta for adult patients with newly diagnosed acute myeloid leukemia. This puts Daiichi Sankyo in competition with Novartis AG's Rydapt and Astellas Pharma Inc's Xospata. The approval was based on the results of the QuANTUM-First trial, which showed a 22% reduction in the risk of death compared to standard chemotherapy alone.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 1:44 pm

MRTX

Mirati Therapeutics shares are trading lower following the announcement that the EMA's CHMP issued a negative opinion on the Conditional Marketing Authorization Application for KRAZATI, a treatment for patients with KRASG12C -mutated advanced NSCLC.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 1:35 pm